DelMar Pharmaceuticals Backtesting

DMPI -- USA Stock  

USD 0.61  0.0259  4.04%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of DelMar Pharmaceuticals and determine expected loss or profit from investing in DelMar Pharmaceuticals over given investment horizon. Additionally see DelMar Pharmaceuticals Hype Analysis, DelMar Pharmaceuticals Correlation, DelMar Pharmaceuticals Valuation, DelMar Pharmaceuticals Volatility as well as analyze DelMar Pharmaceuticals Alpha and Beta and DelMar Pharmaceuticals Performance.
 Time Horizon     30 Days    Login   to change
SymbolX
Backtest

DelMar Pharmaceuticals 'What if' Analysis

June 18, 2018
0.00
No Change 0.00  0.0%
In 31 days
July 18, 2018
0.00
If you would invest  0.00  in DelMar Pharmaceuticals on June 18, 2018 and sell it all today you would earn a total of 0.00 from holding DelMar Pharmaceuticals or generate 0.0% return on investment in DelMar Pharmaceuticals over 30 days. DelMar Pharmaceuticals is related to or competes with China Cord, NantKwest, Denali Therapeutics, Dova Pharmaceuticals, Dicerna Pharmaceuticals, and DYNAVAX TECHNOLOG. DelMar Pharmaceuticals, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-...

DelMar Pharmaceuticals Upside/Downside Indicators

Information Ratio0.42
Maximum Drawdown10.98
Value At Risk6.99
Potential Upside4.78
  

DelMar Pharmaceuticals Market Premium Indicators

Risk Adjusted Performance0.22
Jensen Alpha1.37
Total Risk Alpha2.07
Treynor Ratio12.85

DelMar Pharmaceuticals Backtested Returns

Macroaxis considers DelMar Pharmaceuticals to be risky. DelMar Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.3814 which denotes DelMar Pharmaceuticals had -0.3814% of return per unit of risk over the last 1 month. Macroaxis philosophy towards predicting risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. DelMar Pharmaceuticals exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm DelMar Pharmaceuticals Coefficient Of Variation of 262.21 and Mean Deviation of 2.75 to check risk estimate we provide. Macroaxis gives DelMar Pharmaceuticals performance score of 0 on a scale of 0 to 100. The firm shows Beta (market volatility) of 0.1056 which denotes to the fact that as returns on market increase, DelMar Pharmaceuticals returns are expected to increase less than the market. However during bear market, the loss on holding DelMar Pharmaceuticals will be expected to be smaller as well.. Even though it is essential to pay attention to DelMar Pharmaceuticals historical returns, it is always good to be careful when utilizing equity current trending patterns. Macroaxis philosophy towards predicting future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. DelMar Pharmaceuticals exposes twenty-one different technical indicators which can help you to evaluate its performance. DelMar Pharmaceuticals has expected return of -1.3474%. Please be advised to confirm DelMar Pharmaceuticals Information Ratio as well as the relationship between Value At Risk and Expected Short fall to decide if DelMar Pharmaceuticals past performance will be repeated at some point in the near future.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.02 

Virtually no predictability

DelMar Pharmaceuticals has virtually no predictability. Overlapping area represents the amount of predictability between DelMar Pharmaceuticals time series from June 18, 2018 to July 3, 2018 and July 3, 2018 to July 18, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DelMar Pharmaceuticals price movement. The serial correlation of 0.02 indicates that only 2.0% of current DelMar Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient 0.02
Spearman Rank Test 0.29
Average Price 0.67
Lagged Average Price 0.73

DelMar Pharmaceuticals lagged returns against current returns

 Current and Lagged Values 
      Timeline 

DelMar Pharmaceuticals regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

DelMar Pharmaceuticals Lagged Returns

 Regressed Prices 
      Timeline 

Did you try this?

Run Crypto Portfolio Optimizer Now
   

Crypto Portfolio Optimizer

Optimize portfolio of digital coins and token across multiple currency and exchanges
All  Next Launch Crypto Portfolio Optimizer

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for DelMar Pharmaceuticals and China Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see DelMar Pharmaceuticals Hype Analysis, DelMar Pharmaceuticals Correlation, DelMar Pharmaceuticals Valuation, DelMar Pharmaceuticals Volatility as well as analyze DelMar Pharmaceuticals Alpha and Beta and DelMar Pharmaceuticals Performance. Please also try Money Managers module to screen money managers from public funds and etfs managed around the world.